Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study

29 Apr 2020

Abstract excerpt

Objectives In December 2019, there was an outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, and since then, the disease has been increasingly spread throughout the world. Unfortunately, the information about early prediction factors for disease progression is relatively limited. Therefore, there is an urgent need to investigate the risk factors of developing severe disease. The objective of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood properties and coagulation
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32352397
DOI: 10.1515/cclm-2020-0377

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective studyPMID 32352397Read ↗

Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.Semantic proximity Read ↗

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patientsSemantic proximity Read ↗

Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, ChinaSemantic proximity Read ↗

Platelet-to-lymphocyte ratio (PLR), a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysisSemantic proximity Read ↗

Exploration of prognostic factors for critical COVID-19 patients：a nomogram analysisSemantic proximity Read ↗

Lymphocyte Count is a Universal Predictor to the Health Status and Outcomes of Patients with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Regression AnalysisSemantic proximity Read ↗

Lymphocyte count is a universal predictor to the health status and outcomes of patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-regression analysisSemantic proximity Read ↗

Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, ChinaSemantic proximity Read ↗

Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, ChinaSemantic proximity Read ↗

Implications of Laboratory Tests in Disease Grading and Death Risk-Stratification of COVID-19: A Retrospective Study in Wuhan, ChinaSemantic proximity Read ↗

Risk Factors for In-hospital Progression of Ordinary COVID-19 in Wuhan, China: A Retrospective Cohort StudySemantic proximity Read ↗

Clinical characteristics and laboratory indicator analysis of 67 COVID-19 pneumonia patients in Suzhou, ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.